Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13

Background. When 12-to-21-year-olds start using prescription pain relievers extra-medically, some of them transition into opioid dependence within 12 months after such use. Our main aim for this epidemiological research on 12-to-21-year-olds in the United States (US) is to estimate the risk of becom...

Full description

Bibliographic Details
Main Authors: Maria A. Parker, James C. Anthony
Format: Article
Language:English
Published: PeerJ Inc. 2015-10-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/1340.pdf
_version_ 1797424050786533376
author Maria A. Parker
James C. Anthony
author_facet Maria A. Parker
James C. Anthony
author_sort Maria A. Parker
collection DOAJ
description Background. When 12-to-21-year-olds start using prescription pain relievers extra-medically, some of them transition into opioid dependence within 12 months after such use. Our main aim for this epidemiological research on 12-to-21-year-olds in the United States (US) is to estimate the risk of becoming a newly incident case of opioid dependence within 12 months after onset of using prescription pain relievers extra-medically (EMPPR).Methods. Meta-analyses from multiple independent replication samples now are possible, based upon nationally representative survey samples of US adolescents age 12–21 years. All 12-to-21-year-olds were sampled and recruited for the US National Surveys on Drug Use and Health, with standardized assessments of EMPPR use and opioid dependence (NSDUH, 2002–2013).Results. Peak risk for a transition from start of EMPPR use to opioid dependence within 12 months is seen at mid-adolescence among 14-to-15-year-olds (6.3%, 8.7% per year), somewhat earlier than peak risk for starting EMPPR use (seen for 16-to-19-year-olds at 4.1%, 5.9% per year). Applied to 12-to-21-year-olds in the US between 2002–2013, an estimated 8 million started using PPR extra-medically. Each year, roughly 42,000 to 58,000 transitioned into opioid dependence within 12 months after onset of such use.Discussion. These epidemiological estimates for the US in recent years teach us to expect one transition into adolescent-onset opioid dependence within 12 months for every 11–16 newly incident EMPPR users, yielding perhaps 120 newly incident opioid dependent cases in need of practitioner attention or treatment services, each day of each year. This evidence can be used to motivate more effective public health prevention, outreach, and early intervention programs as might prevent or delay occurrence of EMPPR use and opioid dependence.
first_indexed 2024-03-09T07:56:42Z
format Article
id doaj.art-752540ad8d2c4cd29f22bfc72150b07a
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T07:56:42Z
publishDate 2015-10-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-752540ad8d2c4cd29f22bfc72150b07a2023-12-03T00:59:47ZengPeerJ Inc.PeerJ2167-83592015-10-013e134010.7717/peerj.1340Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13Maria A. Parker0James C. Anthony1Department of Epidemiology & Biostatistics, Michigan State University, East Lansing, MI, United StatesDepartment of Epidemiology & Biostatistics, Michigan State University, East Lansing, MI, United StatesBackground. When 12-to-21-year-olds start using prescription pain relievers extra-medically, some of them transition into opioid dependence within 12 months after such use. Our main aim for this epidemiological research on 12-to-21-year-olds in the United States (US) is to estimate the risk of becoming a newly incident case of opioid dependence within 12 months after onset of using prescription pain relievers extra-medically (EMPPR).Methods. Meta-analyses from multiple independent replication samples now are possible, based upon nationally representative survey samples of US adolescents age 12–21 years. All 12-to-21-year-olds were sampled and recruited for the US National Surveys on Drug Use and Health, with standardized assessments of EMPPR use and opioid dependence (NSDUH, 2002–2013).Results. Peak risk for a transition from start of EMPPR use to opioid dependence within 12 months is seen at mid-adolescence among 14-to-15-year-olds (6.3%, 8.7% per year), somewhat earlier than peak risk for starting EMPPR use (seen for 16-to-19-year-olds at 4.1%, 5.9% per year). Applied to 12-to-21-year-olds in the US between 2002–2013, an estimated 8 million started using PPR extra-medically. Each year, roughly 42,000 to 58,000 transitioned into opioid dependence within 12 months after onset of such use.Discussion. These epidemiological estimates for the US in recent years teach us to expect one transition into adolescent-onset opioid dependence within 12 months for every 11–16 newly incident EMPPR users, yielding perhaps 120 newly incident opioid dependent cases in need of practitioner attention or treatment services, each day of each year. This evidence can be used to motivate more effective public health prevention, outreach, and early intervention programs as might prevent or delay occurrence of EMPPR use and opioid dependence.https://peerj.com/articles/1340.pdfPrescription pain relieversOpioidsAdolescentsDependenceTransitionEpidemiology
spellingShingle Maria A. Parker
James C. Anthony
Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13
PeerJ
Prescription pain relievers
Opioids
Adolescents
Dependence
Transition
Epidemiology
title Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13
title_full Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13
title_fullStr Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13
title_full_unstemmed Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13
title_short Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12–21 year olds in the United States using meta-analysis, 2002–13
title_sort epidemiological evidence on extra medical use of prescription pain relievers transitions from newly incident use to dependence among 12 21 year olds in the united states using meta analysis 2002 13
topic Prescription pain relievers
Opioids
Adolescents
Dependence
Transition
Epidemiology
url https://peerj.com/articles/1340.pdf
work_keys_str_mv AT mariaaparker epidemiologicalevidenceonextramedicaluseofprescriptionpainrelieverstransitionsfromnewlyincidentusetodependenceamong1221yearoldsintheunitedstatesusingmetaanalysis200213
AT jamescanthony epidemiologicalevidenceonextramedicaluseofprescriptionpainrelieverstransitionsfromnewlyincidentusetodependenceamong1221yearoldsintheunitedstatesusingmetaanalysis200213